ClinicalTrials.gg
Sign In
CompletedNCT03720587Updated Sep 8, 2023

The Experiences of Patients With Greater Trochanteric Pain Syndrome.

An observational study in Greater Trochanteric Pain Syndrome, sponsored by The Royal Orthopaedic Hospital NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2023-09-08.

Sponsored by The Royal Orthopaedic Hospital NHS Trust · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
10
Ages
16 Years and older
Sex
All
01

Study summary

Greater Trochanteric Pain syndrome (GTPS) is a debilitating condition causing pain on the outside of the hip. This study aims to explore the experiences, beliefs and expectations of patients with GTPS, using semi-structured interviews.

Read the detailed description

Greater Trochanteric Pain syndrome (GTPS) is a debilitating condition causing pain on the outside of the hip. There is growing evidence to suggest that psychological barriers to recovery are present in patients with peripheral pain. The experiences and beliefs of patients suffering with GTPS are unknown. This study aims to explore the experiences, beliefs and expectations of patients with GTPS, using semi-structured interviews to inform the development of interventions for evaluation in future research.

02

Conditions studied

  • Greater Trochanteric Pain Syndrome

Keywords

  • GTPS
  • Gluteal tendinopathy
  • Lateral hip pain
  • Trochanteric bursitis
03

In context

Lead sponsor

The Royal Orthopaedic Hospital NHS Trust is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Study participants will be identified from Orthopaedic clinic lists and the Outpatient Physiotherapy waiting list at a single, elective Orthopaedic NHS Trust. Patients will have been assessed in a Specialist Consultant lead clinic by and been given one of the following diagnoses:

  1. Lateral Hip pain
  2. Greater Trochanteric Pain Syndrome (GTPS)
  3. Trochanteric bursitis.
  4. Gluteal tendinopathy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults > 16
  • Able to speak and understand the English language
  • Patients seen in a Specialist Consultant lead clinic who have been given the diagnosis of lateral hip pain, Greater Trochanteric Pain Syndrome (GTPS), Trochanteric Bursitis or Gluteal Tendinopathy.

Exclusion criteria

Exclusion Criteria:

  • Inflammatory conditions
  • Systemic / Infective disease
  • Previous diagnosis of Fibromyalgia or persistent multi-joint pain.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
10 participants (actual)
Patient registry
No

Interventions

  • OtherSemi-structured interviews

    Semi-struuctured telephone interviews

06

What researchers measure

Primary outcomes

  1. Framework Method of data analysis.

    A systematic approach to qualitative analysis specifically used when the objectives of a study are known, prior to analysis

    Time frame: 10 months

07

Study locations

1 site
  • The Royal Orthopaedic Hospital NHS Trust
    Birmingham, United Kingdom
08

References and documents

Publications

  • Stephens G, O'Neill S, Mottershead C, Hawthorn C, Yeowell G, Littlewood C. "It's just like a needle going into my hip, basically all of the time". The experiences and perceptions of patients with Greater Trochanteric Pain syndrome in the UK National Health Service. Musculoskelet Sci Pract. 2020 Jun;47:102175. doi: 10.1016/j.msksp.2020.102175. Epub 2020 Apr 29. PubMed 32452392 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2018 to primary completion in Apr 2019, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2018
First posted
Oct 25, 2018
StartActual
Dec 1, 2018
Primary completionActual
Apr 12, 2019
CompletionActual
Apr 12, 2019
Last update
Sep 8, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03720587
Lead sponsor
The Royal Orthopaedic Hospital NHS Trust
Responsible party
Sponsor
First posted
Oct 25, 2018
Start date
Dec 1, 2018
Primary completion
Apr 12, 2019
Completion
Apr 12, 2019
Last update
Sep 8, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

The Royal Orthopaedic Hospital NHS Trust

Start the discussion